Literature DB >> 34738195

The essential problem of over-measuring the depth of submucosal invasion in pT1 colorectal cancer.

Daisuke Aizawa1,2, Takashi Sugino3, Takuma Oishi3, Kinichi Hotta4, Kenichiro Imai4, Akio Shiomi5, Akifumi Notsu6, Masahiro Ikegami7, Tadakazu Shimoda3.   

Abstract

A depth of submucosal invasion (DSI) of ≥1000 μm is an important risk factor for lymph node metastasis (LNM) in patients with submucosal invasive (pT1) colorectal cancer (CRC), according to the European Society of Gastrointestinal Endoscopy and the Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines. According to the latter, if the location of the muscularis mucosae in the invasive area is not confirmed, the DSI can be measured from the surface. In these cases, a 'remaining intramucosal lesion' (rIL), which is in the invasive area, is sometimes observed. To avoid over-measuring the DSI, we proposed a 'modified DSI' (mDSI), which excludes the rIL from the JSCCR DSI. We investigated the characteristics and effectiveness of the rIL and mDSI by grouping cases with polypoid growth (PG) and non-polypoid growth (NPG) histologically. Three hundred and thirty-nine consecutive patients with pT1 CRC were examined. LNM was detected in 37 cases. The distribution of the DSI and rIL was significantly higher in PG than in NPG cases (P<0.001). There was no difference in the mDSI distribution between the PG-/NPG-type cases. An rIL was observed in 39% (127/301) of cases, in which the location of the muscularis mucosae could not be determined or estimated and the mDIS could be estimated. In 13% (16/127) of cases, the mDSI was effective (JSCCR DSI ≥1000 and mDSI <1000 μm). Among these 16 cases, 11 (69%) did not have risk factors (mDSI, lymphovascular invasion, budding grade, or special histological types) and may have avoided unnecessary surgery.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Colorectal cancer; Depth of submucosal invasion; Lymph node metastasis; Submucosal invasive cancer

Mesh:

Year:  2021        PMID: 34738195     DOI: 10.1007/s00428-021-03221-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

1.  Risk factors for an adverse outcome in early invasive colorectal carcinoma.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinsuke Aida; Kazuo Hase; Susumu Matsukuma; Tadao Kanai; Hiroyuki Kurihara; Kotaro Ozawa; Kazuyoshi Yoshimura; Shinya Bekku
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

2.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study.

Authors:  Kazuaki Kitajima; Takahiro Fujimori; Shigehiko Fujii; Jun Takeda; Yasuo Ohkura; Hitoshi Kawamata; Toshihide Kumamoto; Shingo Ishiguro; Yo Kato; Tadakazu Shimoda; Akinori Iwashita; Yoichi Ajioka; Hidenobu Watanabe; Toshiaki Watanabe; Tetsuichiro Muto; Ko Nagasako
Journal:  J Gastroenterol       Date:  2004-06       Impact factor: 7.527

3.  A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.

Authors:  Hiroshi Kawachi; Yoshinobu Eishi; Hideki Ueno; Tetsuo Nemoto; Takahiro Fujimori; Akinori Iwashita; Yoichi Ajioka; Atsushi Ochiai; Shingo Ishiguro; Tadakazu Shimoda; Hidetaka Mochizuki; Yo Kato; Hidenobu Watanabe; Morio Koike; Kenichi Sugihara
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

4.  Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

Authors:  Monika Ferlitsch; Alan Moss; Cesare Hassan; Pradeep Bhandari; Jean-Marc Dumonceau; Gregorios Paspatis; Rodrigo Jover; Cord Langner; Maxime Bronzwaer; Kumanan Nalankilli; Paul Fockens; Rawi Hazzan; Ian M Gralnek; Michael Gschwantler; Elisabeth Waldmann; Philip Jeschek; Daniela Penz; Denis Heresbach; Leon Moons; Arnaud Lemmers; Konstantina Paraskeva; Juergen Pohl; Thierry Ponchon; Jaroslaw Regula; Alessandro Repici; Matthew D Rutter; Nicholas G Burgess; Michael J Bourke
Journal:  Endoscopy       Date:  2017-02-17       Impact factor: 10.093

Review 5.  Endoscopic mucosal resection of flat and depressed types of early colorectal cancer.

Authors:  S Kudo
Journal:  Endoscopy       Date:  1993-09       Impact factor: 10.093

6.  A pathological study on colorectal cancer. From de novo carcinoma to advanced carcinoma.

Authors:  M Ikegami
Journal:  Acta Pathol Jpn       Date:  1987-01

Review 7.  Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions.

Authors:  Steven L Bosch; Steven Teerenstra; Johannes H W de Wilt; Chris Cunningham; Iris D Nagtegaal
Journal:  Endoscopy       Date:  2013-07-24       Impact factor: 10.093

8.  Histopathologic risk factors for lymph node metastasis in patients with T1 colorectal cancer.

Authors:  Ryun Kyong Ha; Kyung Su Han; Dae Kyung Sohn; Byung Chang Kim; Chang Won Hong; Hee Jin Chang; Jong Hee Hyun; Min Jung Kim; Sung Chan Park; Jae Hwan Oh
Journal:  Ann Surg Treat Res       Date:  2017-10-27       Impact factor: 1.859

9.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Naohiko Yamaguchi; Toshiaki Tanaka; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2017-03-27       Impact factor: 3.402

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Authors:  Yojiro Hashiguchi; Kei Muro; Yutaka Saito; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Kiyoshi Hasegawa; Kinichi Hotta; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Yusuke Kinugasa; Keiko Murofushi; Takako Eguchi Nakajima; Shiro Oka; Toshiaki Tanaka; Hiroya Taniguchi; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Takeharu Yamanaka; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Michio Itabashi; Kentaro Sakamaki; Keiji Sano; Yasuhiro Shimada; Shinji Tanaka; Hiroyuki Uetake; Shigeki Yamaguchi; Naohiko Yamaguchi; Hirotoshi Kobayashi; Keiji Matsuda; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2019-06-15       Impact factor: 3.402

View more
  1 in total

1.  Risk Factors for Predicting Lymph Node Metastasis in Submucosal Colorectal Cancer.

Authors:  Kurumi Tsuchihashi; Norikatsu Miyoshi; Shiki Fujino; Masatoshi Kitakaze; Masayuki Ohue; Katsuki Danno; Itsuko Nakamichi; Kenji Ohshima; Eiichi Morii; Mamoru Uemura; Yuichiro Doki; Hidetoshi Eguchi
Journal:  J Anus Rectum Colon       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.